| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028859491 |
| P356 | DOI | 10.1023/A:1018476631561 |
| P698 | PubMed publication ID | 9427435 |
| P2093 | author name string | Key TJ | |
| Thomas HV | |||
| Reeves GK | |||
| P433 | issue | 6 | |
| P304 | page(s) | 922-928 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Cancer Causes & Control | Q325957 |
| P1476 | title | Endogenous estrogen and postmenopausal breast cancer: a quantitative review | |
| P478 | volume | 8 |
| Q44231749 | A prospective study of adiposity and postmenopausal breast cancer risk: the Malmö Diet and Cancer Study |
| Q35774129 | A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk |
| Q57274808 | Androgen Receptor Gene Alterations in Finnish Male Breast Cancer |
| Q34558074 | Angiotensin AT(2) receptor contributes towards gender bias in weight gain |
| Q40409564 | Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women |
| Q35612285 | Biological rationale for endocrine therapy in breast cancer |
| Q37529650 | Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in China. |
| Q47414005 | Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). |
| Q44842659 | Bone mass density and risk of breast cancer and survival in older women |
| Q38520697 | Bone mineral density and the risk of breast cancer: the Rotterdam Study |
| Q34057720 | Breast cancer hypothesis: a single cause for the majority of cases |
| Q34224822 | Breast cancer: hormones and other risk factors |
| Q77541715 | Breast electrical impedance and estrogen use in postmenopausal women |
| Q44487660 | Can breast cancer be chemoprevented in 2003? |
| Q39426379 | Chronic leptin treatment sensitizes MCF-7 breast cancer cells to estrogen |
| Q33296544 | Design of the sex hormones and physical exercise (SHAPE) study |
| Q35010135 | Divergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues |
| Q35036644 | Educational differences in postmenopausal breast cancer--quantifying indirect effects through health behaviors, body mass index and reproductive patterns |
| Q46367637 | Effect of dietary flaxseed on serum levels of estrogens and androgens in postmenopausal women. |
| Q33654025 | Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies |
| Q52006900 | Epidemiology of breast cancer--selected highlights. |
| Q34771417 | Epidemiology of endocrine-related risk factors for breast cancer |
| Q33646842 | Estrogen signaling and the DNA damage response in hormone dependent breast cancers |
| Q37618657 | Estrogen- and stress-induced DNA damage in breast cancer and chemoprevention with dietary flavonoid |
| Q36840495 | Estrogens in the breast tissue: a systematic review |
| Q36643784 | Ethnic differences in ovulatory function in nulliparous women |
| Q36620269 | Exposure to female hormone drugs during pregnancy: effect on malformations and cancer |
| Q37353676 | Fruit intake associated with urinary estrogen metabolites in healthy premenopausal women |
| Q24803306 | Future possibilities in the prevention of breast cancer: fat and fiber and breast cancer research |
| Q37393210 | Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk |
| Q37384632 | Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China |
| Q43873468 | Glycemic index, hyperinsulinemia, and breast cancer risk |
| Q35965644 | Hormonal and genetic risk factors for breast cancer. |
| Q34688660 | Hormone-replacement therapy and breast cancer |
| Q53650136 | In vitro metabolism of hydroxylated polybrominated diphenyl ethers and their inhibitory effects on 17β-estradiol metabolism in rat liver microsomes. |
| Q36349807 | Influence of obesity on timing of puberty |
| Q33765174 | Is green tea drinking associated with a later onset of breast cancer? |
| Q53485998 | Is hormone replacement therapy safe for breast cancer patients? |
| Q36615256 | Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). |
| Q27022929 | Mechanisms linking excess adiposity and carcinogenesis promotion |
| Q33544121 | Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer |
| Q24796091 | Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. |
| Q37210759 | Minireview: Obesity and breast cancer: the estrogen connection |
| Q46701862 | Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer |
| Q37750871 | Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. |
| Q36620430 | Oestradiol and sex hormone-binding globulin in premenopausal and post-menopausal meat-eaters, vegetarians and vegans |
| Q34531648 | Phytoestrogens and breast cancer risk. Review of the epidemiological evidence |
| Q35570073 | Phytoestrogens: Potential Benefits and Implications for Breast Cancer Survivors |
| Q56882445 | Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women |
| Q53699628 | Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study. |
| Q37608402 | Preventive oncology in the postmenopausal woman. |
| Q37380757 | Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer |
| Q50504227 | Red wine may decrease endogenous estrogen levels in premenopausal women, but does this protect against breast cancer? |
| Q36276855 | SNP discovery, expression and cis-regulatory variation in the UGT2B genes |
| Q35084794 | Second cancers in survivors of childhood cancer |
| Q36641110 | Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan |
| Q25255845 | Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [ISRCTN08045231]. |
| Q64897388 | The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors. |
| Q94154671 | The Macrobiotic Diet as Treatment for Cancer: Review of the Evidence |
| Q41916020 | The Relationship between Bone Mineral Density and Estrogen Receptor Positivity in Patients with Breast Cancer |
| Q26766454 | The Role of Steroid Hormones in the Modulation of Neuroinflammation by Dietary Interventions |
| Q37560211 | The association between different kinds of fat intake and breast cancer risk in women |
| Q26861527 | The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise |
| Q30397121 | The macrobiotic diet in chronic disease |
| Q35824073 | The multiethnic cohort study: exploring genes, lifestyle and cancer risk |
| Q34364786 | The wisdom of hormone-replacement therapy in survivors of ovarian and endometrial cancer |
| Q36799332 | Total dietary fat and omega-3 fatty acids have modest effects on urinary sex hormones in postmenopausal women |
| Q36621458 | Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey |
| Q33959716 | Use of risk determinants for different breast cancer prevention strategies |
Search more.